Information sur le laboratoire

Peter Lakatos (M.D.)

Chercheur
Unité de recherche clinique
Département de médecine (McGill)

Profil de recherche

 Fondamentale: 0%
 Clinique: 50%
 Épidémiologique: 0%
 Évaluative: 50%
 Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

Mots-clés

Maladie inflammatoire des intestins (MICI) • gastroentérologie • colite • maladie de Crohn

Membre de l'équipe

Nom Poste

Dernières publications

  1. Kritzinger, J., Kotrri, G., Lakatos, P. L., Bessissow, T. & Wild, G. (2025). The Role of Biomarkers in Surveillance of Ulcerative Colitis-Associated Colorectal Cancer: A Scoping Review. Journal of clinical medicine, vol. 14.
  2. Farkas, B., Resál, T., Lakatos, P. L., Bessissow, T., Limdi, J. K., Armuzzi, A., Bezzio, C., Savarino, E. V., Saibeni, S., Michalopoulos, G., Attauabi, M., Seidelin, J. B., Fousekis, F. S., Katsanos, K., Bacsur, P., Bálint, A., Ivány, E., Szepes, Z., Farkas, K. & Molnár, T. (2025). Upadacitinib is associated with better clinical and biochemical outcomes than tofacitinib in refractory, moderate-to-severe UC. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
  3. Balogh, F., Gonczi, L., Angyal, D., Golovics, P. A., Pandur, T., David, G., Erdelyi, Z., Szita, I., Ilias, A., Lakatos, L. & Lakatos, P. L. (2025). Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort. World journal of gastroenterology, vol. 31, p. 109800.
  4. Balogh, F., Angyal, D., Varga, A., Gonczi, L., Lontai, L., Ilias, A. & Lakatos, P. L. (2025). Efficacy and safety of biosimilars in gastroenterology: a focus on inflammatory bowel disease management. Expert opinion on biological therapy, p. 1-12.
  5. Caron, B., Jairath, V., Sands, B. E., Rubin, D. T., Allocca, M., Laurent, V., Novak, K., Panaccione, R., Bossuyt, P., Bruining, D. H., Dignass, A., Dotan, I., Fletcher, J., Fumery, M., Furfaro, F., Halfvarson, J., Hart, A., Kobayashi, T., Cleveland, N. K., Kucharzik, T., Laghi, A., Lakatos, P. L., Leong, R. W., Loftus, E. V., Louis, E., Magro, F., Olivera, P. A., Shaji, S., Siegmund, B., Vavricka, S. R., Danese, S., Stoker, J. & Peyrin-Biroulet, L. (2025). International Magnetic Resonance Imaging Consensus for use in Luminal Crohn's Disease Trials and Clinical Practice. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
  6. Li Fraine, S., Marcus, V., Kron, C. M., Lakatos, P. L., Afif, W., Bitton, A., Wild, G. & Bessissow, T. (2025). Impact of Individual Colonic Segment Histological Activity on Disease Relapse in Patients with Ulcerative Colitis. Journal of clinical medicine, vol. 14.
  7. Wetwittayakhlang, P., Ngampech, S., Pattarakulniyom, S. & Lakatos, P. L. (2025). Objective Treatment Targets and Their Correlation with Patient-Reported Outcomes in Inflammatory Bowel Disease: A Real-World Study. Journal of clinical medicine, vol. 14.
  8. De Marco, D., Heron, V., Bitton, A., Bessissow, T., Lakatos, P., Wild, G. & Afif, W. (2025). Assessing the role of ustekinumab dose escalation in Crohn's disease patients with loss of response: an observational study. Journal of the Canadian Association of Gastroenterology, vol. 8, p. 97-102.
  9. Wewer, M. D., Lophaven, S., Lakatos, P. L., Gonczi, L., Salupere, R., Kievit, H. A. L., Nielsen, K. R., Midjord, J., Domislovic, V., Krznarić, Ž., Pedersen, N., Kjeldsen, J., Halfvarson, J., Sebastian, S., Goldis, A., Arebi, N., Oksanen, P., Neumann, A., Andersen, V., Katsanos, K. H., Koukoudis, A., Turcan, S., Ellul, P., Kupcinskas, J., Kiudelis, G., Fumery, M., Kaimakliotis, I. P., D'Inca, R., Lombardini, S., Hernandez, V., Fernandez, A., Langholz, E., Munkholm, P., Burisch, J. & Epi-IBD-group (2025). Long-term disease course of ulcerative colitis in a prospective European population-based inception cohort - an Epi-IBD cohort study. Journal of Crohn's & colitis, vol. 19.
  10. Hanžel, J., Solitano, V., Vuyyuru, S. K., Panaccione, R., Sands, B. E., Peyrin-Biroulet, L., Danese, S., D'Haens, G. R., Atreya, R., Allez, M., Bernstein, C. N., Bossuyt, P., Bressler, B., Bryant, R. V., Cohen, B. L., Colombel, J.-F., D'Amico, F., Dignass, A., Dubinsky, M., Fleshner, P., Gearry, R. B., Hanauer, S. B., Hart, A. L., Kayal, M., Kucharzik, T., Lakatos, P. L., Louis, E., Magro, F., Narula, N., Leong, R. W., Panés, J., Raine, T., Ran, Z., Regueiro, M. D., Reinisch, W., Singh, S., Steinhart, A. H., Travis, S., Ungaro, R. C., Janneke van der Woude, C., Yamamoto, T., Ahuja, V., Rubin, D. T., Dulai, P. S., Cornfield, L. J., Hogan, M., Sandborn, W. J., Feagan, B. G., Jairath, V. & Ma, C. (2025). An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Gastroenterology.
Voir plus sur PubMed 



Voir aussi

Card image
Talat
Bessissow


Voir le profil
Card image
Waqqas
Afif


Voir le profil
Card image
Alain
Bitton


Voir le profil
Card image
Paul
Brassard


Voir le profil
Card image
Matthieu
Allez


Voir le profil
Card image
Bertrand
Lebouché


Voir le profil